Lord, Abbett & Co
CLBT icon

Lord, Abbett & Co’s Cellebrite CLBT Stock Holding History

Lord, Abbett & Co’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-520,804
Closed -$10.1M – 524
2025
Q1 		$10.1M Sell
520,804
-209,535
-29% -$4.41M 0.04% 369
2024
Q4 		$16.1M Buy
730,339
+46,119
+7% +$888K 0.05% 350
2024
Q3 		$11.5M Buy
+684,220
New +$10.2M 0.04% 385

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lord, Abbett & Co's CLBT Position: Q2 2025 in Review

Lord, Abbett & Co sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 520,804 shares — an estimated $10.1M sold.

Lord, Abbett & Co first reported a position in CLBT in Q3 2024 and held it in 3 quarters. The position peaked at $16.1M in Q4 2024. 209 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • Lord, Abbett & Co reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
  • Lord, Abbett & Co sold 520,804 Cellebrite shares in Q2 2025, an estimated $10.1M.
  • Lord, Abbett & Co first reported a position in Cellebrite in Q3 2024 and held it in 3 quarters.
  • Lord, Abbett & Co's Cellebrite position peaked at $16.1M in Q4 2024.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on Lord, Abbett & Co's 13F filing for Q2 2025, filed 14 Aug 2025.